|
FIP1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.59650000000722E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43229999996597E-06 |
| Normal-vs-Stage2 |
1.243330E-04 |
| Normal-vs-Stage3 |
4.481600E-03 |
| Normal-vs-Stage4 |
2.610800E-01 |
| Stage1-vs-Stage2 |
8.110600E-01 |
| Stage1-vs-Stage3 |
3.808400E-01 |
| Stage1-vs-Stage4 |
3.049800E-01 |
| Stage2-vs-Stage3 |
3.143800E-01 |
| Stage2-vs-Stage4 |
2.365800E-01 |
| Stage3-vs-Stage4 |
6.281000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50430000003909E-06 |
| Normal-vs-AfricanAmerican |
8.25380000000209E-05 |
| Normal-vs-Asian |
4.425900E-02 |
| Caucasian-vs-AfricanAmerican |
8.925000E-01 |
| Caucasian-vs-Asian |
8.780800E-01 |
| AfricanAmerican-vs-Asian |
8.251600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.50080000047315E-07 |
| Normal-vs-Female |
5.508400E-02 |
| Male-vs-Female |
2.242200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.571700E-04 |
| Normal-vs-Extreme_Weight |
4.13540000021584E-07 |
| Normal-vs-Obese |
2.201900E-03 |
| Normal-vs-Extreme_Obese |
2.434400E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.258200E-01 |
| Normal_Weight-vs-Obese |
4.635600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.175200E-01 |
| Extreme_Weight-vs-Obese |
6.853900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.125600E-01 |
| Obese-vs-Extreme_Obese |
2.154400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.355380E-01 |
| Normal-vs-Age(41-60Yrs) |
3.618600E-04 |
| Normal-vs-Age(61-80Yrs) |
8.96960000051905E-07 |
| Normal-vs-Age(81-100Yrs) |
3.57180000000179E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.349400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.431800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.720100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.283600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.259800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.957600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.50650000002783E-06 |
| Normal-VS-Type2 PRCC |
3.81220000000848E-06 |
| Normal-VS-KIRP CIMP |
9.255000E-01 |
| Normal-VS-Unclassified PRCC |
6.017200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.735200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.340100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.969350E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.716800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.087400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.770000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.77070000276325E-08 |
| Normal-vs-N1 |
3.592200E-01 |
| Normal-vs-N2 |
1.148380E-01 |
| N0-vs-N1 |
3.762100E-04 |
| N0-vs-N2 |
3.448000E-01 |
| N1-vs-N2 |
4.520200E-01 |
|
|
